Business Services Industry
Daiichi Wins Lawsuit Against Mylan Pharmaceuticals Regarding Patents
JCNN News Summaries - Japan Corporate News Network, Dec 27, 2005 by Aki Tsukioka
Tokyo, Dec 27, 2005 - (JCN) - Daiichi Sankyo has announced that its wholly owned subsidiary Daiichi Pharmaceutical has won the lawsuit against Mylan Pharmaceuticals.
Specifically, the US Court of Appeals for the Federal Circuit has affirmed the validity of US patent (No. 5,053,407) on levofloxacin, a broad spectrum synthetic antibacterial agent held by Daiichi. Consequently, Mylain is prohibited from producing any generic version of levofloxacin until Daiichi's patent expires.
Currently, levofloxacin is marketed under the trade names of Cravit in Japan and Levaquin in the US.
c 2005 Japan Corporate News Network. All rights reserved.
Provided by ProQuest Information and Learning Company. All rights Reserved.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
Most Popular Business Publications
Content provided in partnership with
